India, April 21 -- Amneal Pharmaceutical LLC is recalling two lots of Ropivacaine Hydrochloride Injection Infusion bags to the hospital/user level as they may contain an inert fiber identified as polypropylene fibers from the IV bag, according to the U.S. Food and Drug Administration.
The recalled Ropivacaine Hydrochloride Injection USP, 500mg/100mL, Infusion bags are packed in 12x100mL single-dose IV bags with NDC 70121-17343.
The affected lot numbers are AL240003 and AL240004, both with an expiration date of January 2026. No other lots are affected by the recall.
The impacted product was distributed across the country to wholesalers and distributors between April 23, 2024, and November 8, 2024.
Ropivacaine Hydrochloride Injection is u...